{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:35:12Z","timestamp":1723120512961},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Trop Med Rep"],"published-print":{"date-parts":[[2019,6,15]]},"DOI":"10.1007\/s40475-019-00172-3","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T05:36:12Z","timestamp":1553578572000},"page":"35-41","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunization Strategies for the Control of Histoplasmosis"],"prefix":"10.1007","volume":"6","author":[{"given":"Maxwell T.","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zamith-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Nosanchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"172_CR1","doi-asserted-by":"publisher","first-page":"982","DOI":"10.4269\/ajtmh.14-0175","volume":"90","author":"S Antinori","year":"2014","unstructured":"Antinori S. Histoplasma capsulatum: more widespread than previously thought. Am J Trop Med Hyg. 2014;90:982\u20133.","journal-title":"Am J Trop Med Hyg"},{"key":"172_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1007213","volume":"14","author":"GS Deepe","year":"2018","unstructured":"Deepe GS. Outbreaks of histoplasmosis: the spores set sail. PLoS Pathog. 2018;14:1\u20135.","journal-title":"PLoS Pathog"},{"key":"172_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s40475-015-0044-0","volume":"2","author":"NC Bahr","year":"2015","unstructured":"Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep. 2015;2:70\u201380.","journal-title":"Curr Trop Med Rep"},{"key":"172_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1086\/500405","volume":"42","author":"JH Chu","year":"2006","unstructured":"Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42:822\u20135.","journal-title":"Clin Infect Dis"},{"key":"172_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1378\/chest.29.6.649","volume":"29","author":"NE Manos","year":"1956","unstructured":"Manos NE, Ferebee SH, Kerschbaum WF. Geographic variation in the prevalence of histoplasmin sensitivity. Dis Chest. 1956;29:649\u201368.","journal-title":"Dis Chest"},{"key":"172_CR6","doi-asserted-by":"crossref","unstructured":"Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate epidemiology of histoplasmosis, United States, 2011\u20132014. 2018;24:425\u201331.","DOI":"10.3201\/eid2403.171258"},{"key":"172_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/AAC.41.2.410","volume":"41","author":"J Wheat","year":"1997","unstructured":"Wheat J, Marichal P, Bossche HV, Monte AL, Connolly PA. Hypothesis on the mechanism of resistance to fluconazole in histoplasma capsulatum. Antimicrob Agents Chemother. 1997;41:410\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"172_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1189\/jlb.0308154","volume":"84","author":"GS Deepe","year":"2008","unstructured":"Deepe GS, Gibbons RS, Smulian AG. Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs. J Leukoc Biol. 2008;84:669\u201378 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18577715.","journal-title":"J Leukoc Biol"},{"key":"172_CR9","doi-asserted-by":"publisher","unstructured":"Ray SC, Rappleye CA. Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition. Semin Cell Dev Biol; 2018\" please include \"Available from: https:\/\/doi.org\/10.1016\/j.semcdb.2018.03.009","DOI":"10.1016\/j.semcdb.2018.03.009"},{"key":"172_CR10","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1128\/IAI.68.10.5668-5672.2000","volume":"68","author":"SL Newman","year":"2000","unstructured":"Newman SL, Gootee L, Gabay JE, Selsted ME. Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infect Immun. 2000;68:5668\u201372.","journal-title":"Infect Immun"},{"key":"172_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/fmb.15.25","volume":"10","author":"MC Horwath","year":"2015","unstructured":"Horwath MC, Fecher RA, Deepe G. Histoplasma capsulatum, lung infection and immunity. Future Microbiol. 2015;10:967\u201375.","journal-title":"Future Microbiol"},{"key":"172_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4161\/21505594.2014.965586","volume":"6","author":"SK Thind","year":"2015","unstructured":"Thind SK, Taborda CP, Nosanchuk JD. Dendritic cell interactions with Histoplasma and Paracoccidioides. Virulence. 2015;6:424\u201332.","journal-title":"Virulence."},{"key":"172_CR13","doi-asserted-by":"crossref","unstructured":"Wood KL, Hage CA, Knox KS, Kleiman MB, Sannuti A, Day RB, et al. Histoplasmosis after treatment with anti-tumor necrosis factor-\u03b1 therapy. Am J Respir Crit Care Med. 2003;167:1279\u201382.","DOI":"10.1164\/rccm.200206-563OC"},{"key":"172_CR14","doi-asserted-by":"crossref","unstructured":"Deepe, Jr. GS, Nosanchuk JD. Fungal vaccine development. Mol Princ Fungal Pathog [Internet]. American Society of Microbiology; 2006 [cited 2018 Aug 10]. p. 565\u201381. Available from: http:\/\/www.asmscience.org\/content\/book\/10.1128\/9781555815776.ch38","DOI":"10.1128\/9781555815776.ch38"},{"key":"172_CR15","doi-asserted-by":"crossref","unstructured":"Deepe GS. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity. Clin Infect Dis [Internet]. 2005;41 Suppl 3:S204-7. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15983901.","DOI":"10.1086\/429999"},{"key":"172_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM200010193431605","volume":"343","author":"AP Limaye","year":"2000","unstructured":"Limaye AP, Connolly PA, Sagar M, Fritsche TR, Cookson BT, Wheat LJ, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med. 2000;343:1163\u20136.","journal-title":"N Engl J Med"},{"key":"172_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1128\/IAI.59.1.330-336.1991","volume":"59","author":"AM Gomez","year":"1991","unstructured":"Gomez AM, Rhodes JC, Deepe GS Jr. Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun. 1991;59:330\u20136.","journal-title":"Infect Immun"},{"key":"172_CR18","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1128\/IAI.59.12.4459-4464.1991","volume":"59","author":"FJ Gomez","year":"1991","unstructured":"Gomez FJ, Gomez AM, Deepe GS Jr. Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun. 1991;59:4459\u201364.","journal-title":"Infect Immun"},{"key":"172_CR19","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1128\/IAI.60.7.2565-2571.1992","volume":"60","author":"FJ Gomez","year":"1992","unstructured":"Gomez FJ, Gomez AM, Deepe GS. An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell- mediated immune responses and protection in mice. Infect Immun. 1992;60:2565\u201371.","journal-title":"Infect Immun"},{"key":"172_CR20","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/IAI.63.7.2587-2595.1995","volume":"63","author":"FJ Gomez","year":"1995","unstructured":"Gomez FJ, Allendoerfer R, Deepe GS Jr. Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun. 1995;63:2587\u201395 Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=7911197207696073954related:4mTJ8PE3ym0J%5Cn, http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC173347\/pdf\/632587.pdf.","journal-title":"Infect Immun"},{"key":"172_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/infdis\/174.4.828","volume":"174","author":"G Deepe","year":"1996","unstructured":"Deepe G, Gibbons R, Brunner GD, Gomez FJ. A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis. 1996;174:828\u201334.","journal-title":"J Infect Dis"},{"key":"172_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1286-4579(00)01253-3","volume":"2","author":"KV Clemons","year":"2000","unstructured":"Clemons KV, Darbonne WC, Curnutte JT, Sobel RA, Stevens DA. Experimental histoplasmosis in mice treated with anti-murine interferon- \u03b3 antibody and in interferon-\u03b3 gene knockout mice. Microbes Infect. 2000;2:997\u20131001.","journal-title":"Microbes Infect"},{"key":"172_CR23","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/IAI.65.7.2564-2569.1997","volume":"65","author":"R Allendoerfer","year":"1997","unstructured":"Allendoerfer R, Deepe GS. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun. 1997;65:2564\u20139.","journal-title":"Infect Immun"},{"key":"172_CR24","first-page":"1359","volume":"160","author":"P Zhou","year":"1998","unstructured":"Zhou P, Miller G, Seder RA. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-\u03b1 plays a critical role in maintaining secondary immunity in the absence of IFN-\u03b3. J Immunol. 1998;160:1359\u201368.","journal-title":"J Immunol"},{"key":"172_CR25","doi-asserted-by":"crossref","unstructured":"Deepe GS, Gibbons RS. Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect Immun [Internet]. American Society for Microbiology; 2002 [cited 2018 Jun 14];70:3759\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12065519.","DOI":"10.1128\/IAI.70.7.3759-3767.2002"},{"key":"172_CR26","doi-asserted-by":"crossref","unstructured":"Scheckelhoff M, Deepe GS. The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V\u03b28.1\/8.2+ T Cells. J Immunol [Internet]. 2002;169:5818\u201326. Available from: http:\/\/www.jimmunol.org\/cgi\/doi\/10.4049\/jimmunol.169.10.5818","DOI":"10.4049\/jimmunol.169.10.5818"},{"key":"172_CR27","doi-asserted-by":"publisher","unstructured":"Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov [Internet]. Nature Publishing Group; 2007;6:404\u201314. Available from: https:\/\/doi.org\/10.1038\/nrd2224.","DOI":"10.1038\/nrd2224"},{"key":"172_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2011.00225","volume":"2","author":"AJ Guimar\u00e3es","year":"2011","unstructured":"Guimar\u00e3es AJ, de Cerqueira MD, Nosanchuk JD. Surface architecture of Histoplasma capsulatum. Front Microbiol. 2011;2:1\u201314.","journal-title":"Front Microbiol"},{"key":"172_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1128\/IAI.9.6.1033-1044.1974","volume":"9","author":"MW Reeves","year":"1974","unstructured":"Reeves MW, Pine L, Bradley G. Characterization and evaluation of a soluble antigen complex prepared from the yeast phase of Histoplasma capsulatum. Infect Immun. 1974;9:1033\u201344.","journal-title":"Infect Immun"},{"key":"172_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1128\/CDLI.1.5.563-568.1994","volume":"1","author":"RM Zancop\u00e9-Oliveira","year":"1994","unstructured":"Zancop\u00e9-Oliveira RM, Bragg SL, Reiss E, Peralta JM. Immunochemical analysis of the H and M glycoproteins from Histoplasma capsulatum. Clin Diagn Lab Immunol. 1994;1:563\u20138 Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=368339&tool=pmcentrez&rendertype=abstract.","journal-title":"Clin Diagn Lab Immunol"},{"key":"172_CR31","doi-asserted-by":"publisher","unstructured":"Pine L, Malcolm GB, Gross H, Gray SB. Evaluation of purified H and M antigens of histoplasmin as reagents in the complement fixation test. Sabouraudia [Internet]. 1978;16:257\u201369. Available from: https:\/\/doi.org\/10.1080\/00362177885380361","DOI":"10.1080\/00362177885380361"},{"key":"172_CR32","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1128\/IAI.63.8.3151-3157.1995","volume":"63","author":"GS Deepe","year":"1995","unstructured":"Deepe GS, Durose GG. Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect Immun. 1995;63:3151\u20137.","journal-title":"Infect Immun"},{"key":"172_CR33","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1128\/IAI.69.5.3128-3134.2001","volume":"69","author":"J Deepe","year":"2001","unstructured":"Deepe J, Gibbons R. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect Immun. 2001;69:3128\u201334.","journal-title":"Infect Immun"},{"key":"172_CR34","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1128\/IAI.05350-11","volume":"79","author":"SH Hsieh","year":"2011","unstructured":"\u2022\u2022 Hsieh SH, Lin JS, Huang JH, Wu SY, Chu CL, Kung JT, et al. Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8 + T cells to protect against Histoplasmosis. Infect Immun. 2011;79:4493\u2013502. This paper demonstrated the efficacy of cross-priming a CD8+ T cell response against histoplasmosis. This is significant in that it represents a possible active vaccination strategy for those with compromised immune systems, specifically those suffering from unmanaged HIV infection or AIDS.","journal-title":"Infect Immun"},{"key":"172_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1128\/IAI.15.3.789-795.1977","volume":"15","author":"RP Tewari","year":"1977","unstructured":"Tewari RP, Sharma D, Solotorovsky M, Lafemina R, Balint J. Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect Immun. 1977;15:789\u201395.","journal-title":"Infect Immun"},{"key":"172_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2012.00021","volume":"3","author":"JD Nosanchuk","year":"2012","unstructured":"Nosanchuk JD, Zancop\u00e9-Oliveira RM, Hamilton AJ, Guimar\u00e3es AJ. Antibody therapy for histoplasmosis. Front Microbiol. 2012;3:1\u20137.","journal-title":"Front Microbiol"},{"key":"172_CR37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI19361","volume":"112","author":"JD Nosanchuk","year":"2003","unstructured":"Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS, Casadevall A. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest. 2003;112:1164\u201375.","journal-title":"J Clin Invest"},{"key":"172_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1128\/EC.00036-08","volume":"7","author":"L Shi","year":"2008","unstructured":"Shi L, Albuquerque PC, Lazar-Molnar E, Wang X, Santambrogio L, Gacser A, et al. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell. 2008;7:1109\u201317.","journal-title":"Eukaryot Cell"},{"key":"172_CR39","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es AJ, Frases S, Gomez FJ, Zancop\u00e9-Oliveira RM, Nosanchuk JD. Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect Immun [Internet]. American Society for Microbiology; 2009 [cited 2018 Jun 11];77:1357\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19179416.","DOI":"10.1128\/IAI.01443-08"},{"key":"172_CR40","doi-asserted-by":"crossref","unstructured":"Guimaraes AJ, Frases S, Pontes B, de Cerqueira MD, Rodrigues ML, Viana NB, et al. Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functions. Infect Immun. 2011;79:918\u201327.","DOI":"10.1128\/IAI.00673-10"},{"key":"172_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/EC.00307-07","volume":"7","author":"ML Rodrigues","year":"2008","unstructured":"Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitin-like structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell. 2008;7:602\u20139.","journal-title":"Eukaryot Cell"},{"key":"172_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12540-y","volume":"7","author":"SC Liedke","year":"2017","unstructured":"\u2022\u2022 Liedke SC, Miranda DZ, Gomes KX, Gon\u00e7alves JLS, Frases S, Nosanchuk JD, et al. Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers. Sci Rep. 2017;7:1\u201317. This paper is significant in that WGA-Fc (IgG2a) represents a potentially powerful passive vaccination strategy against diverse mycoses.","journal-title":"Sci Rep"},{"key":"172_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11046-011-9476-9","volume":"173","author":"RA Bryan","year":"2012","unstructured":"\u2022 Bryan RA, Guimar\u00e3es AJ, Hopcraft S, Jiang Z, Bonilla K, Morgenstern A, et al. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Mycopathologia. 2012;173:463\u201371. This paper is significant because it demonstrates that it is possible to develop radio-immunotherapeutics against diverse mycoses. Here, the efficacy of the mAb is not necessarily dependent on cellular immunity and thus, it represents a way of passively vaccinating those with immune deficiencies in antibody-dependent cellular cytotoxicity.","journal-title":"Mycopathologia"},{"key":"172_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11046-011-9485-8","volume":"173","author":"A Qureshi","year":"2012","unstructured":"Qureshi A, Wray D, Rhome R, Barry W, Del Poeta M. Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis. Mycopathologia. 2012;173:419\u201325.","journal-title":"Mycopathologia."},{"key":"172_CR45","doi-asserted-by":"crossref","unstructured":"Mor V, Farnoud AM, Singh A, Rella A, Tanno H, Ishii K, et al. Glucosylceramide administration as a vaccination strategy in mouse models of cryptococcosis. PLoS One. 2016:1\u201315.","DOI":"10.1371\/journal.pone.0153853"},{"key":"172_CR46","doi-asserted-by":"crossref","unstructured":"Rodrigues ML, Shi L, Barreto-Bergter E, Nimrichter L, Farias SE, Rodrigues EG, et al. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. Clin Vaccine Immunol. 2007;14:1372\u20136.","DOI":"10.1128\/CVI.00202-07"},{"key":"172_CR47","doi-asserted-by":"crossref","unstructured":"Rhome R, Singh A, Kechichian T, Drago M, Morace G, Luberto C, et al. Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal. PLoS One. 2011;6:e15572.","DOI":"10.1371\/journal.pone.0015572"},{"key":"172_CR48","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/EC.00208-07","volume":"6","author":"R Rhome","year":"2007","unstructured":"Rhome R, Mcquiston T, Kechichian T, Bielawska A, Hennig M, Drago M, et al. Biosynthesis and immunogenicity of Glucosylceramide in Cryptococcus neoformans and other human pathogens. Eukaryot Cell. 2007;6:1715\u201326.","journal-title":"Eukaryot Cell"},{"key":"172_CR49","doi-asserted-by":"crossref","unstructured":"Dermani FK, Samadi P, Rahmani G, Kohlan AK, Najafi R. PD-1\/PD-L1 immune checkpoint: potential target for cancer therapy. J Cell Physiol. 2018.","DOI":"10.1002\/jcp.27172"},{"key":"172_CR50","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1073\/pnas.0711918105","volume":"105","author":"E Lazar-Molnar","year":"2008","unstructured":"\u2022 Lazar-Molnar E, Gacser A, Freeman GJ, Almo SC, Nathenson SG, Nosanchuk JD. The PD-1\/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci. 2008;105:2658\u201363. Available from: http:\/\/www.pnas.org\/cgi\/doi\/10.1073\/pnas.0711918105. This paper is significant in that it represents a new potential indication for PD-1R mAb.","journal-title":"Proc Natl Acad Sci"},{"key":"172_CR51","doi-asserted-by":"crossref","unstructured":"\u2022 Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, et al. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci. 2014;111:10660\u20135. Available from: http:\/\/www.pnas.org\/cgi\/doi\/10.1073\/pnas.1312789111. This paper is significant because it provided evidence that cytotoxic CD8+ T cells could be raised in vitro against diverse fungi. This engineered specific immunity is invaluable to those with various immunodeficiencies as well to those for whom standard vaccination strategies may not work.","DOI":"10.1073\/pnas.1312789111"}],"container-title":["Current Tropical Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40475-019-00172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40475-019-00172-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40475-019-00172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T14:20:42Z","timestamp":1620051642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40475-019-00172-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6,15]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1007\/s40475-019-00172-3","relation":{},"ISSN":["2196-3045"],"issn-type":[{"value":"2196-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"26 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}